IL100906A - Pharmaceutical compositions comprising carminic acid and optionally one or more quinones - Google Patents

Pharmaceutical compositions comprising carminic acid and optionally one or more quinones

Info

Publication number
IL100906A
IL100906A IL10090692A IL10090692A IL100906A IL 100906 A IL100906 A IL 100906A IL 10090692 A IL10090692 A IL 10090692A IL 10090692 A IL10090692 A IL 10090692A IL 100906 A IL100906 A IL 100906A
Authority
IL
Israel
Prior art keywords
composition
quinone
acid
moles
concentration
Prior art date
Application number
IL10090692A
Other languages
English (en)
Other versions
IL100906A0 (en
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of IL100906A0 publication Critical patent/IL100906A0/xx
Publication of IL100906A publication Critical patent/IL100906A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/02—Hydroxy-anthraquinones; Ethers or esters thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
    • C09B67/0034—Mixtures of two or more pigments or dyes of the same type
    • C09B67/0038—Mixtures of anthraquinones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10090692A 1991-02-13 1992-02-10 Pharmaceutical compositions comprising carminic acid and optionally one or more quinones IL100906A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use

Publications (2)

Publication Number Publication Date
IL100906A0 IL100906A0 (en) 1992-11-15
IL100906A true IL100906A (en) 1996-09-12

Family

ID=10689992

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10090692A IL100906A (en) 1991-02-13 1992-02-10 Pharmaceutical compositions comprising carminic acid and optionally one or more quinones

Country Status (30)

Country Link
EP (1) EP0499467A3 (fr)
JP (1) JPH06505231A (fr)
CN (1) CN1064407A (fr)
AP (1) AP549A (fr)
AU (2) AU1233992A (fr)
BG (1) BG61025B1 (fr)
BR (1) BR9205642A (fr)
CA (1) CA2104009A1 (fr)
CZ (1) CZ166893A3 (fr)
DZ (1) DZ1559A1 (fr)
FI (1) FI933595A7 (fr)
GB (2) GB9103075D0 (fr)
GT (1) GT199200009A (fr)
HU (1) HUT65634A (fr)
IE (1) IE920464A1 (fr)
IL (1) IL100906A (fr)
IN (1) IN178929B (fr)
IS (1) IS3814A (fr)
JO (1) JO1719B1 (fr)
LT (1) LT3197B (fr)
MA (1) MA22443A1 (fr)
MX (1) MX9200622A (fr)
MY (1) MY131098A (fr)
NO (1) NO932681L (fr)
NZ (2) NZ240487A (fr)
OA (2) OA09535A (fr)
SK (1) SK87993A3 (fr)
TN (1) TNSN92015A1 (fr)
WO (1) WO1992014454A1 (fr)
ZA (1) ZA921037B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
IL113025A0 (en) * 1994-03-17 1995-06-29 Radopath Ltd Anti-viral and anti-cancer agents
ATE188870T1 (de) * 1994-10-04 2000-02-15 Lohmann Rudolf Lomapharm Lösungen von anthrachinonen zur parenteralen applikation
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
WO2009021196A1 (fr) 2007-08-08 2009-02-12 Bionovo, Inc. Extraits de ligustrum lucidum et leurs utilisations
WO2009033025A1 (fr) 2007-09-07 2009-03-12 Bionovo, Inc. Extraits œstrogéniques d'asparagus conchinchinensis (lour.) merr de la famille des liliacées et leurs utilisations
US9155770B2 (en) 2007-09-07 2015-10-13 Bionovo, Inc. Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof
JP2010539085A (ja) 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのキバナオウギのエストロゲン性抽出物およびその使用
EP2060562A1 (fr) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dérivés de sulfonate de dioxoanthracène
CA2706330A1 (fr) 2007-11-19 2009-06-04 Bionovo, Inc. Procede de fabrication d'extrait purifie de la scutellaria barbata d.don
EP2219659A4 (fr) 2007-11-19 2010-11-17 Bionovo Inc Procédés de détection et de traitement de cancers utilisant un extrait de scuttelaria barbata
US20090312437A1 (en) * 2008-06-06 2009-12-17 Bionovo, Inc., A Delaware Corporation Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
US9884815B2 (en) * 2011-10-14 2018-02-06 Emory University PGAM1 inhibitors and methods related thereto
CZ304335B6 (cs) * 2012-02-22 2014-03-12 Mikrobiologický ústav AV ČR, v. v. i. Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití
KR20210032405A (ko) * 2018-07-17 2021-03-24 삘리 안트라퀴논 유도체 및 착색제로서의 그의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7708452L (sv) * 1977-07-22 1979-01-23 Allied Chem Komposition innehallande en antrakinonforening
JPS6054286B2 (ja) * 1979-09-18 1985-11-29 江澤 林 免疫増強剤
JPS6043210A (ja) * 1983-08-18 1985-03-07 Tdk Corp 磁気ヘツド及びその製造方法
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DE3601065A1 (de) * 1986-01-16 1987-07-23 Behringwerke Ag Chinon-derivate als antitumormittel
DE3879688T2 (de) * 1987-12-10 1993-07-01 Tsumura & Co Anti-retrovirales arzneimittel.
AU633836B2 (en) * 1988-08-16 1993-02-11 Wellcome Foundation Limited, The Medicaments
WO1991015200A2 (fr) * 1990-04-03 1991-10-17 Radopath Limited Utilisation trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou de maladies virales
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen

Also Published As

Publication number Publication date
GT199200009A (es) 1993-08-06
BG98041A (bg) 1994-05-27
FI933595A0 (fi) 1993-08-13
GB2254554A (en) 1992-10-14
FI933595A7 (fi) 1993-08-13
OA09810A (en) 1994-04-15
ZA921037B (en) 1992-11-25
HU9302347D0 (en) 1993-10-28
IN178929B (fr) 1997-07-19
DZ1559A1 (fr) 2002-02-17
JO1719B1 (en) 1992-12-15
GB9203084D0 (en) 1992-03-25
TNSN92015A1 (fr) 1993-06-08
IE920464A1 (en) 1992-08-12
AU1233992A (en) 1992-09-15
EP0499467A3 (en) 1992-12-16
MY131098A (en) 2007-07-31
AP9200356A0 (en) 1992-04-30
JPH06505231A (ja) 1994-06-16
HUT65634A (en) 1994-07-28
CA2104009A1 (fr) 1992-08-14
SK87993A3 (en) 1993-12-08
OA09535A (en) 1992-11-15
WO1992014454A1 (fr) 1992-09-03
GB2254554B (en) 1995-09-20
NO932681L (no) 1993-10-07
NO932681D0 (no) 1993-07-26
NZ241593A (en) 1995-05-26
MX9200622A (es) 1992-11-01
LTIP329A (en) 1994-08-25
IL100906A0 (en) 1992-11-15
LT3197B (en) 1995-03-27
IS3814A (is) 1992-08-14
CZ166893A3 (en) 1994-03-16
AP549A (en) 1996-11-01
GB9103075D0 (en) 1991-03-27
AU5590696A (en) 1996-08-08
EP0499467A2 (fr) 1992-08-19
BG61025B1 (bg) 1996-09-30
CN1064407A (zh) 1992-09-16
MA22443A1 (fr) 1992-10-01
NZ240487A (en) 1994-03-25
BR9205642A (pt) 1994-06-21

Similar Documents

Publication Publication Date Title
AP549A (en) Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections.
US6811788B2 (en) Combinations and methods for treating neoplasms
US9000036B2 (en) Compositions and methods for targeting of treating neoplasms
Schultz Case study: high-dose intravenous vitamin C in the treatment of a patient with adenocarcinoma of the kidney
Saiki et al. Effect of schedule on activity and toxicity of 5‐azacytidine in acute leukemia: a southwest oncology group study
EP0281380A2 (fr) Interaction synergique d&#39;interleukine-2 d&#39;ARN à double chaîne
US20040101573A1 (en) Injectable composition for cancer treatment
AU662883B2 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
Donelli et al. Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?
CN105380956B (zh) 一种治疗白血病的含艾德拉尼的药物组合物及应用
KR100302994B1 (ko) 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용
FI123756B (fi) Parannettu lisäravinne syövän hoitamiseksi tai ennaltaehkäisemiseksi
RU2129867C1 (ru) Средство для профилактики и лечения инфекционных заболеваний и коррекции патологических состояний живого организма
JP2004315470A (ja) ヨウ化ナトリウム含有製剤
HRP920891A2 (en) Quinone preparation
Burchenal Chemotherapy and radiotherapy—Competitors or partners?
RU2026679C1 (ru) Способ противоопухолевой терапии при первичном раке печени
US20110256236A1 (en) Enhancement of the Anti-Leukemic Effect of Thalidomide
EP2068894B1 (fr) Utilisation de composés de diadamantate de rhénium cis (iii) pour potentialiser l&#39;activité antitumorale des complexes de platine.
KR20230053539A (ko) 2,3,5-치환된 싸이오펜 화합물을 포함하는 병용 투여용 조성물
WO1997025044A1 (fr) Poison topo-isomerase ii et therapie associee a base de derives de bis-dioxypiperazine
Hines et al. Nitrogen mustard as adjunctive chemotherapy for breast carcinoma
KR20040075001A (ko) 신경계 진행에 영향을 주는 방법
JPH0672896A (ja) 腎機能改善薬

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted
RH Patent void